ArticleJournal of managed care & specialty pharmacy2018

Budget Impact Analysis of Eliglustat for the Treatment of Gaucher Disease Type 1 in the United States.

Luba Nalysnyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.